Live
FierceBiotechJenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitationFierceBiotechStroke tech developer Imperative Care nets $100M financingFierceBiotechCrossbow hits $77M series B round to bankroll quiver of T-BoltsBioPharma DiveAspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejectionLonza NewsLonza to relocate around 40 jobs from Switzerland to India - SWI swissinfo.chEndpoints NewsAI startup Basecamp Research announces trillion-gene project10x Genomics Blog10x Genomics shows market leadership with jump to 92 RS rating - MSNEndpoints NewsIonis delays prion disease readout; Arvinas' Parkinson's biomarker dataIlluminaIllumina and Labcorp expand cancer testing collaboration - Investing.comEndpoints NewsFDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potentialIlluminaLabcorp–Illumina cancer pact targets wider access to genomic tests - Stock TitanIlluminaIllumina and Labcorp expand collaboration to broaden access to precision oncology testing - PR Newswire
FierceBiotech Jan 30, 2026

Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program

Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program

Original
Body unavailable. Use the original source.

Directory

59 All